Filters
Other countries
Results: 1 to 16 of 16
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene US, LLC - The Rare Disease Company United States | 1886 | 1858 |
|
Centogene US, LLC - The Rare Disease Company United States | 777 | 770 |
|
UBE3B - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 1 | 1 |
|
UBE3B - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Invitae Microcephalic Primordial Dwarfism and Seckel Syndrome Panel Invitae United States | 48 | 38 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Invitae Microphthalmia, Anophthalmia, Coloboma (MAC) and Anterior Segment Dysgenesis Panel Invitae United States | 130 | 81 |
|
Kaufman Oculocerebrofacial Syndrome (UBE3B Single Gene Test) Fulgent Genetics United States | 52 | 1 |
|
Kaufman Oculocerebrofacial Syndrome: gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 1 |
|
Kaufman Oculocerebrofacial Syndrome , Sequencing UBE3B Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Fulgent Genetics United States | 52 | 1 |
|
Results: 1 to 16 of 16
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.